Navigation Links
New program makes prostate cancer treatment decisions easier
Date:10/22/2013

When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active surveillance over therapy, according to research being presented Wednesday (October 23rd) at the Society for Medical Decision Making annual meeting in Baltimore, Maryland.

A recent clinical study showed that mortality rates for early stage prostate cancer were the same for men who choose active surveillance such as periodic PSA testing and biopsy, versus those who chose to treat their disease immediately with radiation or surgery (N Engl J Med, 367:203, 2012). The research suggested that in cases of low-risk prostate cancer, aggressive treatment may not offer a long term survival benefit, and yet is associated with a number of side effects such as urinary incontinence and sexual problems. However, the vast majority of men diagnosed with low-risk cancer undergo aggressive treatment rather than active surveillance.

To ensure that patients make their treatment decisions based on the most current medical evidence and their own values and preferences, a research team at Thomas Jefferson University led by Ronald E. Myers, Ph.D., developed an online program called the Decision Counseling Program (DCP) to help patients clarify their treatment preference and discuss their options with the clinical team. This online program is unique to Jefferson.

First, patients are shown a printed summary of answers to frequently asked questions by treatment type. Some of the questions include: "What treatment option is best for long term survival?" and "What are the side effects." With the help of a nurse, the patient then identifies the top 3 reasons the patient may or may not want to initiate active surveillance (pros and cons). The patient then ranks those reasons by importance. The nurse enters the reasons and rankings into the online program and generates a 1-page summary report that helps patients visualize their preference to active surveillance versus aggressive treatment. A copy of the report is given to the patient and the clinical team. The report is used as a point of discussion during the patient's clinical visit with an urologist and radiologist.

The research team tested the program with 23 low-risk prostate cancer patients. After participating in the Decision Counseling Program and speaking with the clinical team, 83 percent of the patients decided on active surveillance, rather than aggressive treatment. In addition, says Dr. Myers, "patients were more knowledgeable, and reported feeling more informed, more supported and less conflicted in their decision after going through the program. They understood their options better, and felt like they were making a treatment decision that was right for them."


'/>"/>

Contact: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. Announcing the recipients for the Accelerating Science Award Program
2. Recent Study Shows Short-Term Conditioning Program Improves Tennis Players’ Serve Velocity by Nearly 5 MPH, Announces Performance Health
3. East Meets West with Two of the Best Hospitality Schools in the World Signing a Student Exchange Programme
4. Get Juiced: Review Examines Vince Del Monte and Drew Canole’s New Get Juiced Recipes Program
5. Union College Offers Chemical Dependency Counselor Program Online
6. William Oliver's How to Cure Vitiligo Fast Review Introduces New Healing Program
7. Starting from scratch: RIT program teaches first-year students how to learn
8. Gallo Research Center announces new round of awards for $20m US Army-funded research program
9. Early Literacy Program Significantly Improves Pre-reading Skills in At-Risk Children
10. URAC Names 2013 Health Care Stars! Award Winners at Annual Quality Summit and Awards Program
11. AxoGen, Inc. to Sponsor Surgeon Education Programs on Peripheral Nerve Surgery at American Society for Surgery of the Hand 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... in Beverly Hills, California, will be included in the 2016 “Guide to America’s ... exceptional professionals based on the amalgamation of their education, experience, and professional associations. ...
(Date:12/2/2016)... Wilmington, Delaware (PRWEB) , ... December 02, 2016 ... ... has released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite ... from sample entry through labeling, storing, shipping and disposal. The new version is ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the ... its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition ... has been available in several ShopRite and FoodTown stores in NJ and received rave ...
(Date:12/2/2016)... ... , ... "Pro3rd Accents Volume 2 is a set of 30 accented lower ... just a few clicks of the mouse," said Christina Austin - CEO of Pixel ... from various styles with accented animations, rigid boxes, simplistic lines, and more. In Addition, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... to build intelligent, connected applications, was named the best Sales Team of 2016 ... winner announcement was made today by the Software & Information Industry Association (SIIA), ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... , Dec. 3, 2016  Findings from a ... of CTL019, an investigational chimeric antigen receptor T ... and young adult patients with B-cell acute lymphoblastic ... oral session at the 58th American Society of ... 4:00-5:30 p.m.). The global Phase II study found ...
(Date:12/2/2016)... -- Persistence Market Research (PMR) delivers key ... titled, "Global Market Study on Cardiac Pacemaker: North America Regional ... 2016 and 2024". The global cardiac pacemaker market was valued ... likely to decline to US$ 3923.8 Mn by 2024. ... is anticipated to exhibit a declining CAGR of -0.5% ...
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
Breaking Medicine Technology: